{
  "id": "39745413",
  "title": "Increasing rates of ",
  "doi": null,
  "authors": "Jehanne Q, Bénéjat L, Ducournau A, Aptel J, Pivard M, Gillet L, Jauvain M, Lehours P",
  "journal": "Antimicrobial agents and chemotherapy",
  "year": "2025",
  "abstract": "Macrolides are the first-line compounds used for the treatment of campylobacteriosis. Macrolide resistance remains low in France, with mutations in",
  "source": "PubMed",
  "pmcid": "PMC11823653"
}